Portfolio (Quarterly)
Guide ↗
Davern Capital Partners, LP
· CIK 0002003147| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PFE | PFIZER INC | Healthcare | 1,593,942.0 | $44.8M | 12.28% | -448K | -21.9% | $28.08 | -7.9% |
| 2 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 44,800.0 | $34.6M | 9.49% | -8K | -14.5% | $772.64 | -16.9% |
| 3 | BNTX | BIONTECH SE | Healthcare | 305,055.0 | $27.1M | 7.44% | -66K | -17.8% | $88.88 | +4.1% |
| 4 | ARGX | ARGENX SE | Healthcare | 35,045.0 | $25.6M | 7.02% | -640.0 | -1.8% | $730.25 | +10.3% |
| 5 | RPRX | ROYALTY PHARMA PLC | Healthcare | 520,009.0 | $24.9M | 6.84% | -321K | -38.1% | $47.97 | +12.4% |
| 6 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 873,398.0 | $24.2M | 6.64% | -155K | -15.1% | $27.70 | +7.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
98.0%
Financial Services
2.0%